Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Ameloblastoma × dabrafenib × Clear all

Phase

Phase 2 2 Phase 3 1 Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Ovarian Neoplasms 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasms 1 Multiple Myeloma 1 Lymphoproliferative Disorders 1 Laryngeal Neoplasms 1 Histiocytosis, Langerhans-Cell 1 Hematologic Neoplasms 1 Glioma 1 Gastrointestinal Neoplasms 1 Erdheim-Chester Disease 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Ameloblastoma 1

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06819605 2025-02-11

NETCAM-RCT

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Phase 2/3 Not yet recruiting

Ameloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡